Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$4.69 -0.06 (-1.26%)
At close: Sep 29, 2026 · 4:00 PM EDT

Oramed Pharmaceuticals (ORMP) Dividends payables (2025 - 2026)

Updated

Oramed Pharmaceuticals (ORMP) reported Dividends payables of $264,000 for Q2 2026, down 12.9% from the prior quarter.

Analysis

Oramed Pharmaceuticals (ORMP) Dividends payables (2025 - 2026) Analysis & Trends

At the end of FY2025, Oramed Pharmaceuticals posted Dividends payables of $10.6 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends payables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 2.13 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.45 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Oramed Pharmaceuticals 196.24 Mn 196.24 Mn - 264,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 264,000.00
Mar 31, 2026 303,000.00
Dec 31, 2025 10.60 Mn
API Access

Oramed Pharmaceuticals Dividends payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=dividends-payables&ticker=ORMP&period=max&api_key=YOUR_API_KEY